Truist reiterates Buy on Universal Technical Institute stock at $38
Truist Securities reiterated a Buy rating on Universal Technical Institute (UTI) with a $38 price target, citing potential upside if execution improves. UTI stock is near its 52-week low, down 48% over six months. The company reported a 7.2% revenue increase in Q3 but missed forecasts and lowered its full-year outlook, leading Texas Capital to downgrade the stock to Hold with a $25 target.
How this was made
The 30-second read
Why it matters
The analyst upgrade provides a modest catalyst but is offset by ongoing operational concerns.
Market read
A small analyst upgrade that may generate limited buying interest in UTI.
What to watch
High‑school recruitment challenges remain a material risk to future enrollment growth.
Background
Truist's reiteration follows a recent Q3 earnings release and a downgrade by Texas Capital due to recruitment channel issues.
Ticker impact
Truist reiterated a Buy on Universal Technical Institute with a $38 price target after the company's Q4 guidance and enrollment results.
likely upward pressure as the $38 target suggests near‑term upside.
Analyst upgrade and higher price target can attract buying interest, but recent guidance weakness tempers the move.
Market effects
May slightly improve sentiment for for‑profit education stocks.
Limited to U.S. markets where UTI trades.
Low
Counterpoint
The downgrade by Texas Capital and reduced outlook could outweigh the Truist upgrade.
Key entities
- companyUniversal Technical Institute
For‑profit technical education provider (NYSE:UTI).
- analystTruist Securities
Investment bank issuing the Buy rating and $38 target.
